Chiesi Ventures is the corporate venture capital arm of Chiesi focused on rare and orphan diseases., It aims to complement the strategic interest of Chiesi Group by investing in early-stage development opportunities.
Chiesi Ventures, a separate legal entity from the Group, seeks to accelerate the expansion of the Chiesi network in Europe and in the USA among universities, venture capital investors, rare disease patient organisations, and entrepreneurial companies developing treatments for rare diseases.
Chiesi Ventures recognizes that the advancement of rare disease treatments requires multidisciplinary expertise and a collaborative ecosystem. That’s why we actively engage with leading experts, academic institutions, and industry thought leaders to foster knowledge sharing, drive innovation, and contribute to the overall progress in the field.
Through our strategic investments, we aim to make a meaningful impact on the lives of patients and their families, offering hope and improved outcomes where there were previously limited options.
Read more about us at:
